New York Life Trust’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$7K Sell
60
-650
-92% -$79.5K 0.34% 95
2016
Q4
$89K Buy
710
+259
+57% +$32.7K 0.42% 98
2016
Q3
$60K Sell
451
-247
-35% -$33K 0.3% 118
2016
Q2
$90K Buy
698
+515
+281% +$59.9K 0.44% 81
2016
Q1
$20K Sell
183
-833
-82% -$83K 0.09% 198
2015
Q4
$97K Sell
1,016
-152
-13% -$14.4K 0.42% 96
2015
Q3
$102K Sell
1,168
-161
-12% -$13.8K 0.45% 88
2015
Q2
$106K Buy
1,329
+696
+110% +$55.9K 0.44% 92
2015
Q1
$49K Sell
633
-728
-53% -$59.6K 0.2% 145
2014
Q4
$115K Sell
1,361
-42
-3% -$3.34K 0.45% 92
2014
Q3
$106K Buy
+1,403
New +$109K 0.44% 101
2013
Q3
Sell
-1,420
Closed -$93K 211
2013
Q2
$93K Buy
+1,420
New +$99.8K 0.43% 98

Other funds holding INGR

New York Life Trust's INGR Position: Q1 2017 in Review

New York Life Trust reduced its Ingredion (INGR) stake by 92% in Q1 2017, selling an estimated $79.5K and leaving 60 shares worth $7K. The position accounts for 0.34% of the portfolio, ranked #95.

New York Life Trust first reported a position in INGR in Q2 2013 and has held it in 12 quarters since. The position peaked at $115K in Q4 2014. 478 funds tracked by Wall St. Rank hold INGR as of Q1 2017.

  • New York Life Trust held 60 shares of Ingredion worth $7K as of Q1 2017.
  • New York Life Trust sold 650 Ingredion shares in Q1 2017, an estimated $79.5K.
  • Ingredion made up 0.34% of New York Life Trust's portfolio in Q1 2017, its #95 holding.
  • New York Life Trust first reported a position in Ingredion in Q2 2013 and has held it in 12 quarters since.
  • New York Life Trust's Ingredion position peaked at $115K in Q4 2014.
  • 478 funds tracked by Wall St. Rank held Ingredion as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.